Microchip Technology, Inc.
) expanded its zero-drift operational amplifiers (op amps) with the
launch of its MCP6V11 and MCP6V31 single amplifiers. The intent
behind the introduction of these products was to bring forth a
performance boost in the applications used in the consumer,
industrial and medical markets.
Using a low voltage supply of 1.6V and current of 7.5 µA,
Microchip's advanced amplifiers would ameliorate productivity of
its applications substantially. One area where these products would
be extremely beneficial is the medical sector where highly
productive and inexpensive medical devices are much in demand.
These products would not only provide for optimum productivity but
also be uniquely power efficient.
Management averred that its state-of-the-art technologies allow
for minute power consumption, flexible packaging and highly
productive amplifiers. These not only elevate the power amplifier
technology to a higher pedestal but also allows for market
proliferation and enhancement of goodwill.
On May 1, 2012, the company reported its fourth quarter
financial results of fiscal 2012. Revenues declined around 3%
annually to reach around $339 million for the quarter. It can be
inferred from the current technological advancements that we are
likely to perceive a better performance from the upcoming quarter
Also, the presence of ominous rivals in the industry is
something Microchip should guard itself against. Big players in
this regard include
Maxim Integrated Products Inc.
NXP Semiconductors N.V.
The current Zacks Consensus Estimates for the first quarter of
fiscal 2013 and for fiscal 2013 are 44 cents per share and $1.90
per share, respectively. The company currently retains a Zacks #3
Rank, which translates into a short-term 'Hold' rating. We also
have a 'Neutral' recommendation on the company's stock.
MICROCHIP TECH (MCHP): Free Stock Analysis
MAXIM INTG PDTS (MXIM): Free Stock Analysis
NXP SEMICONDUCT (NXPI): Free Stock Analysis
SUPERTEX INC (SUPX): Free Stock Analysis Report
To read this article on Zacks.com click here.